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Objective: The aim of this study was to explore the analgesic activity of lyophilized juice of Punica granatum L., obtained from Hidalgo, Mexico, in the 
formalin test.
Methods: We extracted the juice manually, filtered it and then dried down in a lyophilizer machine. We evaluated the antinociceptive effect of 
lyophilized juice from pomegranate in the formalin test (2%) in male Wistar rats (180–200 g body weight). Thirty minutes before the test, a dose of 
316 mg/kg (lyophilized juice) and acetylsalicylic acid as reference drug (100 mg/kg) both were administered intragastrically (i.g.).
Results: The oral administration of lyophilized juice of pomegranate showed a significant decrease in the number of flinches in the temporal course 
and a significant antinociceptive effect in nociceptive and inflammatory pain compared with the vehicle. In the same way, this effect appeared with the 
drug of reference (acetylsalicylic acid 100 mg/kg i.g). Furthermore, it was shown that juice had a 34% of antinociception on overall effect versus vehicle.
Conclusion: The results suggest that lyophilized juice of pomegranate has antinociceptive effect in nociceptive and inflammatory pain. Therefore, this 
study supports the possible use of this lyophilized juice of pomegranate in the treatment of pain.
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INTRODUCTION
Pain is a symptom and often is the main cause of seeking professional 
help to get relief. The most common disorders are inflammatory pain 
and nociceptive pain [1]. Nowadays, the pain has become an invisible 
epidemic that affects 20% of the adult population, with clinical and 
socioeconomic consequences, affecting the quality of life [2].
This scenario prompts the search for new compounds with therapeutic 
efficacy to solve these problems [3]. In this regard, natural products 
have played a significant role in developing and discovering new active 
ingredients with analgesic properties [4].
Pomegranate is a tropical and subtropical fruit of a tree called 
pomegranate (Punica granatum L.), and its use is associated with 
multiple beneficial effects on health, due to its bioactive compounds 
(ellagitannins and anthocyanins being the most abundant) [5]. One of 
these effects is its use against pain; in traditional medicine, pomegranate 
has been used for sore throat, toothaches, canker sores, and stomach [6]. 
Moreover, in preclinical studies, it has been shown that the use of 
different extracts from this fruit exhibits antinociceptive effects in 
nociceptive and inflammatory pain [7-10]. Nevertheless, pomegranate 
effects on nociceptive behavior have been poorly explored, and there are 
no studies evaluating this antinociceptive effect in pomegranate varieties 
from Hidalgo, Mexico. In this regard, the objective of this study was to 
evaluate the antinociceptive activity of lyophilized juice of P. granatum 
L., obtained from Hidalgo, Mexico, in the formalin test in rats.
METHODS
Plant material and extraction
P. granatum L. was collected at Tasquillo Municipality in Hidalgo 
State, Mexico, during August–October 2019. The juice was extracted 
manually by squeezing the arils and then, filtered and lyophilized 
using a lyophilizer machine (Labconco Model Freezone 4.5, Kansas 
City, MO, USA) at a temperature of −40°C. Specimen was identified at 
the Botany Department of the Bachelor of Biology from the Institute of 
Basic Sciences and Engineering at Autonomous University of the State 
of Hidalgo. Voucher specimens were deposited at the Pharmacognosy 
Department.
Animals and housing conditions
Male Wistar rats (180–200 g of body weight) were used to perform this 
study. The rats were housed in a room under standardized conditions, 
on a 12 h light/dark cycle with food and water available ad libitum 
before treatment. All experimental procedures were approved by the 
Internal Institutional Animal Care and Use Committee and followed 
the Guidelines on Ethical Standards for Investigations of Experimental 
Pain in Animals [11] and the Official Mexican Norm (NOM-062-
ZOO-1999). In addition, the experimental procedures were approved 
by the Ethical Committee of the Autonomous University of the State of 
Hidalgo (CICUAL010-2019). All tests were performed during the light 
phase. The number of rats was kept at a minimum, and all animals were 
euthanized in the end.
Compound
The concentration of formalin (2%) was prepared by diluting a 
saturated aqueous solution of formaldehyde (37%) (Merck, Mexico) 
with a sterile physiological saline solution.
Acetylsalicylic acid was obtained commercially from Sigma-Aldrich 
(St. Louis, MO, USA). Acetylsalicylic acid was suspended in 0.5% 
carboxymethylcellulose and was administered orally in an application 
volume of 4 ml/kg body weight.
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Measurement of antinociceptive activity
The formalin-induced flinches test was used as previously 
described [12]. All treatments were orally administered 30 min 
before the 2% formalin injection (50 µl) subcutaneously in the dorsal 
right hind paw. The number of flinches (nociceptive behavior) of the 
injected paw was quantified over 1 min, every 5 min, up to 1 h after 
injection. The mean number of flinches constructed time-courses of 
the antinociceptive response of the different treatments. The area 
under the curve (AUC) of the number of flinches against each treatment 
time was calculated [13]. Antinociception is presented as the percent 
antinociception, calculated from AUC of phase 1, phase 2, and the 





Formalin-induced flinching behavior was biphasic [14]. The initial acute 
phase (0–10 min) was followed by a relatively short quiescent period, 
which was then followed by a prolonged tonic response (15–60 min).
Statistical analysis
All data were expressed as the means±SEM and were checked for 
normality using the Shapiro–Wilk test. The antinociceptive response 
was analyzed using an analysis of variance test for between-group 
comparisons, followed by the post hoc Tukey test. In all of the statistical 
analyses, *p<0.05 was considered statistically significant. The studies 
were performed using GraphPad Prism 6.0 software (GraphPad 
Software, Inc., La Jolla, CA, USA).
RESULTS
Fig. 1 shows the time course of the number of flinches in response to 
the administration i.g. of the vehicle, acetylsalicylic acid, and lyophilized 
juice of P. granatum L. in the formalin test (2%). The administration of 
the vehicle showed a significant increase in the number of flinches; this 
behavior reflects a nociceptive behavior. However, the administration 
of both treatments i.g. (acetylsalicylic acid and lyophilized juice) 
showed a significant decrease in the number of flinches, indicating an 
antinociceptive effect.
It is well known that formalin administration produces two phases of 
nociceptive behavior: The first one is directly linked to the stimulation 
of primary sensory neurons and is followed by a second phase, which 
is associated with inflammation and involves central sensitization [14]. 
Fig. 2 shows the oral administration of lyophilized juice of P. 
granatum L., and acetylsalicylic acid exhibited a statistically significant 
antinociceptive effect compared to their control group (*p>0.05) in 
both phases. However, acetylsalicylic acid administration showed a 
more significant antinociceptive effect in phase 2 (inflammatory pain) 
than lyophilized pomegranate juice.
When analyzing both overall phases effect, it can be seen that orally 
administration of acetylsalicylic acid (100 mg/kg, i.g.) and lyophilized 
juice (316 mg/kg, i.g.) showed a statistically significant effect on the 
decrease in nociceptive behavior. This statistically significant effect 
was calculated as the maximum, obtaining the highest percentage of 
antinociception for acetylsalicylic acid 41% and lyophilized juice of 
P. granatum L., 34% (Fig. 3).
DISCUSSION
The formalin test is a robust model to study acute and tonic 
inflammatory pain [14], and it has been demonstrated to be sensitive 
to various analgesic drugs [15]. In the present study, formalin (2%) 
injection produced the expected nociceptive response in rat receiving 
vehicle (0.5% carboxymethylcellulose).
Besides, nonsteroidal anti-inflammatory drugs as diclofenac 
acetylsalicylic acid, indomethacin, and naproxen have been previously 
Fig. 2: Antinociceptive effect observed after oral administration 
of acetylsalicylic acid (100 mg/kg, i.g.) and lyophilized juice (316 
mg/kg, i.g.) during phases 1 and 2 of the 2% formalin test. Data 
were expressed as the percent of antinociception. Each point 
represents the mean±SE, n=6. *p<0.05, significantly different 
from the vehicle group; #p<0.05 acetylsalicylic acid versus 
lyophilized juice
Fig. 1: Temporal course of the effect on the number of flinches 
generated by acetylsalicylic acid and lyophilized juice of Punica 
granatum L., in the formalin test. The animals were administered 
with vehicle (0.5% carboxymethylcellulose) or single doses of 
acetylsalicylic acid (100 mg/kg i.g.) and lyophilized juice of P. 
granatum L. (316 mg / kg i.g.) Each point represents the mean±SE
Fig. 3: Antinociceptive effect observed after oral administration 
of acetylsalicylic acid (100 mg/kg, i.g.) and lyophilized juice (316 
mg/kg, i.g.) during the overall effect of the 2% formalin test. 
Data are expressed as the percent of antinociception. Each point 
represents the mean±SE, n=6. *p<0.05. Significantly different 
from the vehicle group; #p<0.05 acetylsalicylic acid versus 
lyophilized juice
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shown to exhibit clear antinociceptive effects in the formalin test in 
rats [15]. These studies demonstrated that acetylsalicylic acid reduces 
nociceptive behavior in both phases [15] for the block prostaglandin 
synthesis [16]. These results are in agreement with our study.
Different studies have been generated with possible analgesic effects of 
popular medicinal plants [4]. In this sense, the present work shows for 
the first time that lyophilized pomegranate juice from a specific variety 
of the state of Hidalgo showed antinociceptive effects in the early 
phase (activation of peripheral nociceptors) and late phase (reflects 
the ongoing peripheral activity and central sensitization related to an 
inflammatory pain). Our findings agree with similar results obtained 
by other groups of researchers; it has been reported that some 
pomegranate products that include juice and seed extracts [17], extracts 
of flowers [18], leaves, fruit peel [19], seeds [17], or whole fruit [7], 
have shown antinociceptive and anti-inflammatory effects [7]. These 
findings were performed in different phases and various experimental 
models [7,20]. These effects may be attributed to their diverse bioactive 
phytochemicals as ellagitannins, ellagic acid, or anthocyanins [7], 
which may be attributed to its antioxidant capacity. The effect of 
pomegranate antioxidant compounds on pain modulation is related to 
the elimination of free radicals [21], decreases macrophage oxidative 
stress [22], and enhances the biological actions of naturally produced 
nitric oxide (NO) [23-25]. There is also evidence that shows that the NO 
acts as a modulator in the spinal cord and dorsal root ganglia through 
the nociceptive pathway [26].
However, the precise mechanism by which pomegranate products and 
their bioactive phytochemicals enhances the analgesia has not been 
completely clarified yet. Therefore, more studies should be carried 
out to know the possible mechanisms related to the pomegranate 
antinociceptive effect.
CONCLUSION
This is the first study to demonstrate that lyophilized juice of 
pomegranate obtained from the state of Hidalgo, Mexico, reduces 
painful behavior in nociceptive and inflammatory pain. Nevertheless, 
future research is needed to discern the possible action mechanisms 
responsible for this effect.
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